Compare LBRX & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LBRX | AMAL |
|---|---|---|
| Founded | 2015 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2025 | 2020 |
| Metric | LBRX | AMAL |
|---|---|---|
| Price | $47.00 | $48.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $46.60 | $36.00 |
| AVG Volume (30 Days) | ★ 285.4K | 130.8K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | ★ 98.22 | N/A |
| EPS | N/A | ★ 1.99 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.18 |
| Revenue Next Year | N/A | $6.55 |
| P/E Ratio | ★ N/A | $24.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.40 | $25.13 |
| 52 Week High | $50.16 | $51.59 |
| Indicator | LBRX | AMAL |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 55.41 |
| Support Level | $21.90 | $36.50 |
| Resistance Level | $49.65 | $51.25 |
| Average True Range (ATR) | 2.02 | 0.95 |
| MACD | -0.53 | -0.20 |
| Stochastic Oscillator | 30.43 | 53.75 |
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.